Travasol 1.15 g (Arginine SOLUTION) 1.15 G

TRAVASOL 1.15 G is an intravenous solution containing arginine, designed to support nutritional needs. This product is manufactured by Baxter Corporation in Canada and is available in a 3000 mL pack size.

Strength

1.15 G

Pack Size

3000

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRAVASOL 1.15 G is used to provide essential amino acids, including arginine, for patients who cannot obtain adequate nutrition through oral intake. It is often used in clinical settings to support nutritional therapy and maintain overall health during periods of inadequate dietary intake.

Side Effects

When administered intravenously, TRAVASOL 1.15 G delivers arginine and other amino acids directly into the bloodstream. This can help support various bodily functions, including protein synthesis and immune response. Patients may experience improved nutritional status and overall well-being.

Precautions & Warnings

TRAVASOL 1.15 G should be used under medical supervision. It is important to follow proper administration guidelines to avoid complications. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

TRAVASOL 1.15 G may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional.

Frequently Asked Questions

TRAVASOL 1.15 G is used to provide essential amino acids, including arginine, for patients who cannot obtain adequate nutrition through oral intake.

TRAVASOL 1.15 G is administered intravenously under medical supervision.

TRAVASOL 1.15 G delivers arginine and other amino acids directly into the bloodstream, supporting protein synthesis and immune response.

TRAVASOL 1.15 G should be used under medical supervision, and patients with certain medical conditions or allergies should consult their healthcare provider.

TRAVASOL 1.15 G may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.